Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No.

× No keyword cloud information.

6 in total

1. Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.

Authors: S G Shelat; P Smith; J Ai; X L Zheng
Journal: J Thromb Haemost Date: 2006-08 Impact factor: 5.824

Review 2. Thrombotic microangiopathy with targeted cancer agents.

Authors: John A Blake-Haskins; Robert J Lechleider; Robert J Kreitman
Journal: Clin Cancer Res Date: 2011-08-03 Impact factor: 12.531

Review 3. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.

Authors: Suresh G Shelat; Jihui Ai; X Long Zheng
Journal: Semin Thromb Hemost Date: 2005-12 Impact factor: 4.180

4. Idiopathic combined, autoantibody-mediated ADAMTS-13/factor H deficiency in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in a 17-year-old woman: a case report.

Authors: Daniel Patschan; Peter Korsten; Arne Behlau; Radovan Vasko; Malte Heeg; Nadera Sweiss; Gerhard A Müller; Michael Koziolek
Journal: J Med Case Rep Date: 2011-12-29

5. Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI).

Authors: Chike Nzerue; Kemi Oluwole; David Adejorin; Paisit Paueksakon; Richard Fremont; Richmond Akatue; Marquetta Faulkner
Journal: Clin Kidney J Date: 2014-11-13

6. CD4(+)CD25(+) T Cells in primary malignant hypertension related kidney injury.

Authors: Hongdong Huang; Yang Luo; Yumei Liang; Xidai Long; Youming Peng; Zhihua Liu; Xiaojun Wen; Meng Jia; Ru Tian; Chengli Bai; Cui Li; Fuliang He; Qiushi Lin; Xueyan Wang; Xiaoqun Dong
Journal: Sci Rep Date: 2016-06-09 Impact factor: 4.379

6 in total